Gemmer Asset Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-99
Closed -$2K 1362
2019
Q3
$2K Buy
99
+4
+4% +$99 ﹤0.01% 1241
2019
Q2
$2K Hold
95
﹤0.01% 1236
2019
Q1
$2K Hold
95
﹤0.01% 1265
2018
Q4
$2K Hold
95
﹤0.01% 1205
2018
Q3
$3K Hold
95
﹤0.01% 1177
2018
Q2
$3K Hold
95
﹤0.01% 1191
2018
Q1
$3K Hold
95
﹤0.01% 1174
2017
Q4
$3K Hold
95
﹤0.01% 1114
2017
Q3
$2K Hold
95
﹤0.01% 1194
2017
Q2
$2K Hold
95
﹤0.01% 1185
2017
Q1
$2K Buy
+95
New +$1.97K ﹤0.01% 1178

Other funds holding EDIT

Gemmer Asset Management's EDIT Position: Q4 2019 in Review

Gemmer Asset Management sold out of Editas Medicine (EDIT) in Q4 2019, closing a stake of 99 shares — an estimated $2K sold.

Gemmer Asset Management first reported a position in EDIT in Q1 2017 and held it in 11 quarters. The position peaked at $3K in Q3 2018. 229 funds tracked by Wall St. Rank hold EDIT as of Q4 2019.

  • Gemmer Asset Management reported no remaining Editas Medicine position as of Q4 2019 after selling out during the quarter.
  • Gemmer Asset Management sold 99 Editas Medicine shares in Q4 2019, an estimated $2K.
  • Gemmer Asset Management first reported a position in Editas Medicine in Q1 2017 and held it in 11 quarters.
  • Gemmer Asset Management's Editas Medicine position peaked at $3K in Q3 2018.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2019.

Based on Gemmer Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.